Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

SLN suspensions work as well as commercial solutions for minoxidil delivery, but are non-corrosive, making them a promising alternative.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Nanotechnology improves minoxidil treatment for hair loss.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Niosomes are a promising and effective way to deliver drugs through the skin.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.